ProfileGDS5822 / ILMN_2959976
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 78% 64% 64% 76% 59% 71% 68% 70% 72% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1104.178
GSM1276600PDAC Late Ablation Control 237.464
GSM1276601PDAC Late Ablation Control 344.364
GSM1276602PDAC Late Ablation 188.976
GSM1276603PDAC Late Ablation 229.359
GSM1276604PDAC Late Ablation 364.771
GSM1303940PDAC Late Ablation_anti-CTLA4 141.268
GSM1303941PDAC Late Ablation_anti-CTLA4 270.470
GSM1303942PDAC Late Ablation_anti-CTLA4 38572